HomeHealthcare & Life Sciences Candida Auris Infection Market

Candida Auris Infection Market Size, Share, Growth & Forecast Analysis Report By Type (Diagnostics, Therapeutics, Infection Control Products), By End Use (Hospitals, Diagnostic Laboratories, Research Institutes), By Distribution Channel (Hospital Procurement, Retail Pharmacy, Online Supply) & Regional Outlook 2026–2034

Starting From
USD 3950

Buy Now

Report Benefits

Develop business strategies by understanding the trends shaping and driving the Market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track sales in the global and country-specific Market.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Executive Summary
1. Introduction
Market Introduction
1. Market Definition
2. Scope of the Study
3. Market Structure
Research Methodology
1. Primary Research
2. Research Methodology
3. Assumptions & Exclusions
4. Secondary Data Sources
Market Factor Analysis
1. Value Chain Analysis: Candida Auris Infection Market
2. Porters Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of Substitution
  4. Threat of New Entrants
  5. Competitive Rivalry
Market Dynamics
1. Drivers
2. Restraints
3. Opportunities
Recent Trends Analysis
Impact of COVID-19 on Candida Auris Infection Market
1. Pre and Post Covid -19 Market Scenario Analysis
2. Market Recovery Timeline and Challenge
3. Measures Taken by Top Players
Regulatory Landscape
Candida Auris Infection Market, By Type
1. Introduction
  1. Market Size and Forecast, By Type
2. Diagnostics
  1. Market Size and Forecast, By Region
3. Therapeutics
  1. Market Size and Forecast, By Region
4. Infection Control Products
  1. Market Size and Forecast, By Region
Candida Auris Infection Market, By End Use
1. Introduction
  1. Market Size and Forecast, By End Use
2. Hospitals
  1. Market Size and Forecast, By Region
3. Diagnostic Laboratories
  1. Market Size and Forecast, By Region
4. Research Institutes
  1. Market Size and Forecast, By Region
Candida Auris Infection Market, By Distribution Channel
1. Introduction
  1. Market Size and Forecast, By Distribution Channel
2. Hospital Procurement
  1. Market Size and Forecast, By Region
3. Retail Pharmacy
  1. Market Size and Forecast, By Region
4. Online Supply
  1. Market Size and Forecast, By Region
Regional Overview
1. Introduction
  1. Market Size and Forecast
2. North America
  1. Market Size and Forecast
    1. By Type
      1. Diagnostics
      2. Therapeutics
      3. Infection Control Products
    2. By End Use
      1. Hospitals
      2. Diagnostic Laboratories
      3. Research Institutes
    3. By Distribution Channel
      1. Hospital Procurement
      2. Retail Pharmacy
      3. Online Supply
  2. U.S.
    1. By Type
      1. Diagnostics
      2. Therapeutics
      3. Infection Control Products
    2. By End Use
      1. Hospitals
      2. Diagnostic Laboratories
      3. Research Institutes
    3. By Distribution Channel
      1. Hospital Procurement
      2. Retail Pharmacy
      3. Online Supply
  3. Canada
3. Europe
  1. Market Size and Forecast
    1. By Type
      1. Diagnostics
      2. Therapeutics
      3. Infection Control Products
    2. By End Use
      1. Hospitals
      2. Diagnostic Laboratories
      3. Research Institutes
    3. By Distribution Channel
      1. Hospital Procurement
      2. Retail Pharmacy
      3. Online Supply
  2. U.K.
    1. By Type
      1. Diagnostics
      2. Therapeutics
      3. Infection Control Products
    2. By End Use
      1. Hospitals
      2. Diagnostic Laboratories
      3. Research Institutes
    3. By Distribution Channel
      1. Hospital Procurement
      2. Retail Pharmacy
      3. Online Supply
  3. Germany
  4. France
  5. Spain
  6. Italy
  7. Russia
  8. Nordic
  9. Benelux
  10. Rest of Europe
4. APAC
  1. Market Size and Forecast
    1. By Type
      1. Diagnostics
      2. Therapeutics
      3. Infection Control Products
    2. By End Use
      1. Hospitals
      2. Diagnostic Laboratories
      3. Research Institutes
    3. By Distribution Channel
      1. Hospital Procurement
      2. Retail Pharmacy
      3. Online Supply
  2. China
    1. By Type
      1. Diagnostics
      2. Therapeutics
      3. Infection Control Products
    2. By End Use
      1. Hospitals
      2. Diagnostic Laboratories
      3. Research Institutes
    3. By Distribution Channel
      1. Hospital Procurement
      2. Retail Pharmacy
      3. Online Supply
  3. South Korea
  4. Japan
  5. India
  6. Australia
  7. Singapore
  8. Taiwan
  9. South East Asia
  10. Rest of Asia-Pacific
5. Middle East and Africa
  1. Market Size and Forecast
    1. By Type
      1. Diagnostics
      2. Therapeutics
      3. Infection Control Products
    2. By End Use
      1. Hospitals
      2. Diagnostic Laboratories
      3. Research Institutes
    3. By Distribution Channel
      1. Hospital Procurement
      2. Retail Pharmacy
      3. Online Supply
  2. UAE
    1. By Type
      1. Diagnostics
      2. Therapeutics
      3. Infection Control Products
    2. By End Use
      1. Hospitals
      2. Diagnostic Laboratories
      3. Research Institutes
    3. By Distribution Channel
      1. Hospital Procurement
      2. Retail Pharmacy
      3. Online Supply
  3. Turky
  4. Saudi Arabia
  5. South Africa
  6. Egypt
  7. Nigeria
  8. Rest of MEA
6. LATAM
  1. Market Size and Forecast
    1. By Type
      1. Diagnostics
      2. Therapeutics
      3. Infection Control Products
    2. By End Use
      1. Hospitals
      2. Diagnostic Laboratories
      3. Research Institutes
    3. By Distribution Channel
      1. Hospital Procurement
      2. Retail Pharmacy
      3. Online Supply
  2. Brazil
    1. By Type
      1. Diagnostics
      2. Therapeutics
      3. Infection Control Products
    2. By End Use
      1. Hospitals
      2. Diagnostic Laboratories
      3. Research Institutes
    3. By Distribution Channel
      1. Hospital Procurement
      2. Retail Pharmacy
      3. Online Supply
  3. Mexico
  4. Argentina
  5. Chile
  6. Colombia
  7. Rest of LATAM
Competitive Landscape, 2025
1. Introduction
2. Candida Auris Infection Market Share Analysis, 2025 (%)
  1. Market Share Analysis, 2025
  2. Competition Ranking, 2025
  3. Key Developments & Growth Strategies
    1. Merger & Acquisition
    2. Product Launch
    3. Expansion
  4. Consolidated SWOT Analysis of Key Players
Company Profile
1. Pfizer Inc.
  1. Business Overview
  2. Financial Data
  3. Key Product Categories
  4. Recent Developments
2. Merck & Co., Inc.
3. F. Hoffmann-La Roche Ltd
4. Thermo Fisher Scientific Inc.
5. bioMérieux SA
6. Abbott Laboratories
7. Siemens Healthineers AG
8. Becton, Dickinson and Company
9. Cepheid (Danaher Corporation)
10. Bruker Corporation
11. Gilead Sciences, Inc.
12. Astellas Pharma Inc.
13. Novartis AG
14. GlaxoSmithKline plc
15. Sun Pharmaceutical Industries Ltd

Report Benefits

Table of Contents